Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY Ethanol producers could face problems during the summer driving season when demand is expected to…
Op-Eds
New Drug Demagoguery
“New Drugs Hit the Market, but Promised Trials Go Undone” and “FDA: Drug Companies Drop Ball on Studies,” the headlines blared.
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS The Senate passes a budget resolution which includes provisions allowing oil and gas exploration in…
Op-Eds
Wi-fi? Why Not?
Walking around a corner, one never knows what will appear. Yet in order to move forward, it’s often necessary to turn corners anyway,…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. FINANCE The Securities and Exchange Commission may ease corporate accounting regulations on small public…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY Many of the hurricane-damaged energy facilities in the Gulf Coast are still offline. CEI…